Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from OrbusNeich Medical Group Holdings Limited ( (HK:6929) ).
OrbusNeich Medical Group Holdings Limited has announced the composition of its board of directors effective 22 January 2026, confirming three executive directors, one non-executive director and three independent non-executive directors. The company has also set out the updated membership of its three key board committees—Audit, Remuneration and Nomination—clarifying which directors serve as chairs and members, a move that formalizes its governance structure and reinforces board oversight for shareholders and other stakeholders.
The most recent analyst rating on (HK:6929) stock is a Hold with a HK$4.00 price target. To see the full list of analyst forecasts on OrbusNeich Medical Group Holdings Limited stock, see the HK:6929 Stock Forecast page.
More about OrbusNeich Medical Group Holdings Limited
OrbusNeich Medical Group Holdings Limited, incorporated in the Cayman Islands and listed in Hong Kong (Stock Code: 6929), operates in the medical device sector, focusing on interventional cardiovascular solutions and related technologies for global healthcare markets.
Average Trading Volume: 139,479
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.19B
For an in-depth examination of 6929 stock, go to TipRanks’ Overview page.